Natural Killer Dendritic Cells Enhance Immune Responses Elicited by α-Galactosylceramide-Stimulated Natural Killer T Cells

被引:14
|
作者
Lee, Sung Won [1 ]
Park, Hyun Jung [1 ]
Kim, Nayoung [2 ]
Hong, Seokmann [1 ]
机构
[1] Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Seoul 143747, South Korea
[2] Asan Med Ctr, Asan Inst Life Sci, Seoul 138736, South Korea
关键词
NKT CELLS; INNATE; PROLIFERATION; CYTOTOXICITY; EXPRESSION; PANCREAS; TREGS; GAMMA; MICA;
D O I
10.1155/2013/460706
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Natural killer dendritic cells (NKDCs) possess potent anti-tumor activity, but the cellular effect of NKDC interactions with other innate immune cells is unclear. In this study, we demonstrate that the interaction of NKDCs and natural killer T (NKT) cells is required for the anti-tumor immune responses that are elicited by alpha-galactosylceramide (alpha-GC) in mice. The rapid and strong expression of interferon-gamma by NKDCs after alpha-GC stimulation was dependent on NKT cells. Various NK and DC molecular markers and cytotoxic molecules were up-regulated following alpha-GC administration. This up-regulation could improve NKDC presentation of tumor antigens and increase cytotoxicity against tumor cells. NKDCs were required for the stimulation of DCs, NK cells, and NKT cells. The strong anti-tumor immune responses elicited by alpha-GC may be due to the down-regulation of regulatory T cells. Furthermore, the depletion of NKDCs dampened the tumor clearance mediated by alpha-GC-stimulated NKT cells in vivo. Taken together, these results indicate that complex interactions of innate immune cells might be required to achieve optimal anti-tumor immune responses during the early stages of tumorigenesis.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Invariant natural killer T cells promote immune tolerance by preferential apoptosis of conventional dendritic cells
    Ribeiro, Moraes E.
    Schmid, H.
    Dong, R.
    Secker, K. -A.
    Keppeler, H.
    Duerr-Stoerzer, S.
    Schneidawind, C.
    Schneidawind, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 241 - 241
  • [42] Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies
    Fujii, Shin-ichiro
    TRENDS IN IMMUNOLOGY, 2008, 29 (05) : 242 - 249
  • [43] Skin dendritic cells present lipid antigens to natural killer T cells
    Stoitzner, P.
    Hermans, I. F.
    Romani, N.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 14 - 15
  • [44] Natural killer dendritic cells are novel immune responders to hepatic metastases
    Burt, B. M.
    Plitas, G.
    Nguyen, H. M.
    Bamboat, Z. M.
    DeMatteo, R. P.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 21 - 21
  • [45] Innate immune responses involving natural killer and natural killer T cells promote liver regeneration after partial hepatectomy in mice
    Hosoya, Satoko
    Ikejima, Kenichi
    Takeda, Kazuyoshi
    Arai, Kumiko
    Ishikawa, Sachiko
    Yamagata, Hisafumi
    Aoyama, Tomonori
    Kon, Kazuyoshi
    Yamashina, Shunhei
    Watanabe, Sumio
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2013, 304 (03): : G293 - G299
  • [46] Natural Killer Cells Enhance Transplantation Outcomes
    Cooley, Sarah A.
    BLOOD, 2014, 124 (21)
  • [47] Immune privilege: Keeping an eye on natural killer T cells
    Hong, S
    Van Kaer, L
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (09): : 1197 - 1200
  • [48] Natural killer T cells and asthma
    Kay, AB
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (11): : 1186 - 1188
  • [49] Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
    Vremec, David
    O'Keeffe, Meredith
    Hochrein, Hubertus
    Fuchsberger, Martina
    Carninschi, Irina
    Lahoud, Mireille
    Shortman, Ken
    BLOOD, 2007, 109 (03) : 1165 - 1173
  • [50] Invariant Natural Killer T Cells
    Cianferoni, Antonella
    ANTIBODIES, 2014, 3 (01): : 16 - 36